Therapeutic effect of MIP-1α-recruited dendritic cells on preestablished solid and metastatic tumors

被引:17
作者
Cao, Qi [1 ,2 ]
Jin, Yanliang [3 ]
Jin, Min [1 ,2 ]
He, Shan [1 ,2 ]
Gu, Qiaoli [4 ]
He, Songbing [4 ]
Qiu, Yuhua [5 ]
Ge, Hailiang [1 ,2 ]
Yoneyama, Hiroyuki [6 ]
Zhang, Yanyun [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Inst Med Sci, Shanghai 200025, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Affiliated Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[5] Soochow Univ, Dept Immunol, Suzhou, Peoples R China
[6] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 113, Japan
基金
中国国家自然科学基金;
关键词
Cancer; Immunotherapy; Dendritic cells; HEMATOPOIETIC PROGENITOR CELLS; EFFICIENT ANTITUMOR IMMUNITY; COLONY-STIMULATING FACTOR; IN-VITRO; LYMPH-NODES; CANCER-IMMUNOTHERAPY; CD8-T-CELL MEMORY; CD4-T-CELL HELP; PIVOTAL ROLE; CROSS-TALK;
D O I
10.1016/j.canlet.2010.02.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously found that dendritic cell (DC) precursors could be recruited into the peripheral blood of B6 mice by administration of macrophage inflammatory protein (MIP)-1 alpha. These MIP-1 alpha-recruited DCs could induce anti-tumor protective immunity when pulsed with tumor cell lysate. In this study, MIP-1 alpha-recruited DCs could not effectively suppress preestablished tumor when pulsed with B16 tumor cell lysate. However, inoculation with these DCs expressing MACE-1 induced an anti-tumor immunity against preestablished solid and metastatic tumor from B16-MACE-1 cells. These MIP-1 alpha-recruited DCs expressed higher level of CCR7 and displayed a more significant chemotactic response toward secondary lymphoid tissue. Therefore, they are superior in the induction of cytotoxic T lymphocytes and the inhibition of tumor development and metastasis than bone marrow-derived DCs. This study established a novel approach to the treatment of preestablished solid and metastatic tumors using MIP-1 alpha-recruited DCs transduced with tumor antigen gene. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 47 条
[1]   Migration of dendritic cell based cancer vaccines:: in vivo veritas? [J].
Adema, GJ ;
de Vries, IJM ;
Punt, CJA ;
Figdor, CG .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (02) :170-174
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   Dendritic cells as therapeutic vaccines against cancer [J].
Banchereau, J ;
Palucka, AK .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (04) :296-306
[4]  
Brossart MDP, 2002, TRANSFUS APHER SCI, V27, P183
[5]   Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: Enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1 [J].
Bueler, H ;
Mulligan, RC .
MOLECULAR MEDICINE, 1996, 2 (05) :545-555
[6]   Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells [J].
Chen, Z ;
Moyana, T ;
Saxena, A ;
Warrington, R ;
Jia, ZC ;
Xiang, J .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) :539-548
[7]   Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein [J].
Cho, Hyun-Il ;
Kim, Eun-Kyung ;
Park, Soo-Young ;
Lee, Su Kyung ;
Hong, Yong-Kil ;
Kim, Tai-Gyu .
CANCER LETTERS, 2007, 258 (02) :189-198
[8]  
Davila E, 2003, CANCER RES, V63, P3281
[9]   MHC class II presentation of endogenously expressed antigens by transfected dendritic cells [J].
Diebold, SS ;
Cotten, M ;
Koch, N ;
Zenke, M .
GENE THERAPY, 2001, 8 (06) :487-493
[10]  
Eggert AAO, 1999, CANCER RES, V59, P3340